NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
24 mai 2023 16h05 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
04 mai 2023 16h05 HE
|
NeuroPace, Inc.
First quarter 2023 revenue increased 27% year-over-year to $14.5 million Full-year revenue guidance updated on strength of first quarter performance. Now expected to be $52-$54 million, up from...
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
17 avr. 2023 16h05 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
03 avr. 2023 16h05 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
02 mars 2023 16h05 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
10 févr. 2023 08h00 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
09 janv. 2023 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
21 déc. 2022 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
08 nov. 2022 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference
04 nov. 2022 16h03 HE
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...